Page last updated: 2024-08-23

amikacin and mocetinostat

amikacin has been researched along with mocetinostat in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Binienda, A; Fichna, J; Kordek, R; Majchrzak, K; Małecka-Panas, E; Salaga, M; Zatorski, H; Zielińska, M1
Beytur, A; Cinar, K; Dogan, Z; Ekinci, N; Ekincioglu, Z; Kose, E; Soysal, H; Turkoz, Y; Vardi, N1

Other Studies

2 other study(ies) available for amikacin and mocetinostat

ArticleYear
AdipoRon, an Orally Active, Synthetic Agonist of AdipoR1 and AdipoR2 Receptors Has Gastroprotective Effect in Experimentally Induced Gastric Ulcers in Mice.
    Molecules (Basel, Switzerland), 2021, May-15, Volume: 26, Issue:10

    Topics: Administration, Oral; Animals; Catalase; Diclofenac; Disease Models, Animal; Ethanol; Male; Mice; Omeprazole; Oxidative Stress; Peroxidase; Piperidines; Receptors, Adiponectin; Stomach Ulcer; Superoxide Dismutase; Treatment Outcome

2021
The effects of montelukast against amikacin-induced acute renal damage.
    European review for medical and pharmacological sciences, 2012, Volume: 16, Issue:4

    Topics: Acetates; Acute Disease; Amikacin; Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; Blood Urea Nitrogen; Creatinine; Cyclopropanes; Cytoprotection; Disease Models, Animal; Female; Glutathione; Immunohistochemistry; Interleukin-1beta; Kidney; Kidney Diseases; Malondialdehyde; Peroxidase; Quinolines; Rats; Rats, Wistar; Sulfides; Tumor Necrosis Factor-alpha

2012